A
Amy Li
Researcher at The Chinese University of Hong Kong
Publications - 13
Citations - 2312
Amy Li is an academic researcher from The Chinese University of Hong Kong. The author has contributed to research in topics: Gut flora & Microbiome. The author has an hindex of 4, co-authored 7 publications receiving 720 citations.
Papers
More filters
Journal ArticleDOI
Alterations in Gut Microbiota of Patients With COVID-19 During Time of Hospitalization.
Tao Zuo,Fen Zhang,Grace Lui,Yun Kit Yeoh,Amy Li,Hui Zhan,Yating Wan,Arthur C.K. Chung,Chun Pan Cheung,Nan Chen,Christopher K C Lai,Zigui Chen,Eugene Y.K. Tso,Kitty S. C. Fung,Veronica L. Chan,Lowell Ling,Gavin M. Joynt,David S.C. Hui,Francis K.L. Chan,Paul K.S. Chan,Siew C. Ng +20 more
TL;DR: Fecal microbiota alterations were associated with fecal levels of SARS-CoV-2 and COVID-19 severity, and strategies to alter the intestinal microbiota might reduce disease severity.
Journal ArticleDOI
Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19.
Yun Kit Yeoh,Tao Zuo,Grace Lui,Fen Zhang,Qin Liu,Amy Li,Arthur C.K. Chung,Chun Pan Cheung,Eugene Y.K. Tso,Kitty S. C. Fung,Veronica L. Chan,Lowell Ling,Gavin M. Joynt,David S.C. Hui,Kai Ming Chow,Susanna So Shan Ng,Timothy Li,Rita W Y Ng,Terry Cheuk-Fung Yip,Grace Lai-Hung Wong,Francis K.L. Chan,Chun K. Wong,Paul K.S. Chan,Siew C. Ng +23 more
TL;DR: In this article, the authors investigated whether the gut microbiome is linked to disease severity in patients with COVID-19, and whether perturbations in microbiome composition, if any, resolve with clearance of the SARS-CoV-2 virus.
Journal ArticleDOI
Alterations in Fecal Fungal Microbiome of Patients With COVID-19 During Time of Hospitalization until Discharge.
Tao Zuo,Hui Zhan,Fen Zhang,Qin Liu,Eugene Y.K. Tso,Grace Lui,Nan Chen,Amy Li,Wenqi Lu,Francis K.L. Chan,Paul K.S. Chan,Siew C. Ng +11 more
TL;DR: Heterogeneous configurations of the fecal mycobiome are found, with enrichment of fungal pathogens from the genera Candida and Aspergillus, during hospitalization of 30 patients with COVID-19 compared with controls.
Journal ArticleDOI
Gut microbiota dynamics in a prospective cohort of patients with post-acute COVID-19 syndrome
Qian Liu,Joyce Wing Yan Mak,Qi Su,Yun Kit Yeoh,Grace Lui,Susanna S.S. Ng,Fen Zhang,Amy Li,Wenqi Lu,David S.C. Hui,Paul K.S. Chan,Francis K.L. Chan,Siew C. Ng +12 more
TL;DR: Findings provided observational evidence of compositional alterations of gut microbiome in patients with long-term complications of COVID-19, and gut microbiota composition at admission was associated with occurrence of PACS.
Journal ArticleDOI
Prolonged impairment of short-chain fatty acid and L-isoleucine biosynthesis in gut microbiome in patients with COVID-19.
Fen Zhang,Jamidu H. Y. Katima,Yating Wan,Tao Zuo,Yun Kit Yeoh,Qin Liu,Lin Zhang,Hui Zhan,Wenqi Lu,Wenye Xu,Grace Lui,Amy Li,Chun Pan Cheung,Chun-Kwok Wong,Paul K.S. Chan,Francis K.L. Chan,Siew C. Ng +16 more
TL;DR: In this paper, a functional profile of the gut microbiome in patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is associated with altered gut microbiota composition.